Pharma company announces potential new drug for COVID patients

A new drug developed by Taipei-based Foresee Pharmaceuticals Co. to treat acute respiratory distress syndrome (ARDS) in COVID-19 patients has received the approval of an independent data monitoring committee (IDMC) in the United States.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)